Literature DB >> 7955238

Preoperative determinants of postoperative costs associated with coronary artery bypass graft surgery.

L R Smith1, C A Milano, B S Molter, J R Elbeery, D C Sabiston, P K Smith.   

Abstract

BACKGROUND: Procedure-related costs are of increasing concern in selecting the appropriate procedure for the treatment of coronary artery disease (CAD). METHODS AND
RESULTS: To determine what preoperative factors influence total postoperative hospital costs, data on 604 coronary artery bypass graft surgery (CABG) patients from 1990 to 1991 were analyzed. Professional fees were excluded. Hospital costs were computed by multiplying patient charges by the Medicare cost-to-charge ratio used in determining federal reimbursement. Median postoperative cost was $12,912 (range $7100 to $259,546). Data were analyzed with a semiparametric regression model. Patients dying in the hospital were censored at time of death. There were significant differences among surgeons in costs but no significant differences in operative mortality. Significant risk factors for increased cost after adjusting for surgeon were: older age (P < .0001), lower left ventricular ejection fraction (P < .0001), prior CABG (P < .0001), female sex (P < .0049), no prior percutaneous transluminal coronary angioplasty (P < .0091), increased degree of CAD (P < .0102), black race (P < .0190), and diabetes (P < .032).
CONCLUSIONS: These results suggest that preoperative characteristics have important economic and medical implications. Surgeons should compare their management strategies on the basis of data analysis to determine the most effective practice with regard to mortality and cost.

Entities:  

Mesh:

Year:  1994        PMID: 7955238

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  9 in total

Review 1.  Does coronary artery bypass grafting improve quality of life in elderly patients?

Authors:  Kamran Baig; Leanne Harling; Joseph Papanikitas; Saina Attaran; Hutan Ashrafian; Roberto Casula; Thanos Athanasiou
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-05-27

2.  The use of patient mix-adjusted control charts to compare in-hospital costs of care.

Authors:  E L Eisenstein; C F Bethea
Journal:  Health Care Manag Sci       Date:  1999-12

3.  Predictors of hospital readmission two years after coronary artery bypass grafting.

Authors:  J Herlitz; P Albertsson; G Brandrup-Wognsen; H Emanuelsson; M Haglid; M Hartford; A Hjalmarson; B W Karlson; T Karlsson; W Sandén
Journal:  Heart       Date:  1997-05       Impact factor: 5.994

4.  A clinical economics workstation for risk-adjusted health care cost management.

Authors:  E L Eisenstein; J W Hales
Journal:  Proc Annu Symp Comput Appl Med Care       Date:  1995

5.  Surgeons' economic profiles: can we get the "right" answers?

Authors:  Eric L Eisenstein; Charles F Bethea; Lawrence H Muhlbaier; Marie Davidian; Eric D Peterson; Judith A Stafford; Daniel B Mark
Journal:  J Med Syst       Date:  2005-04       Impact factor: 4.460

6.  Modeling the costs and outcomes of cardiovascular surgery.

Authors:  James G Anderson; William Harshbarger; H C Weng; Stephen J Jay; Marilyn M Anderson
Journal:  Health Care Manag Sci       Date:  2002-04

7.  Coronary artery bypass grafting in diabetics: A growing health care cost crisis.

Authors:  Sajjad Raza; Joseph F Sabik; Ponnuthurai Ainkaran; Eugene H Blackstone
Journal:  J Thorac Cardiovasc Surg       Date:  2015-04-01       Impact factor: 5.209

8.  Assessing the economic attractiveness of coronary artery revascularization in chronic kidney disease patients.

Authors:  Eric L Eisenstein; Jie L Sun; Kevin J Anstrom; Elizabeth R DeLong; Lynda A Szczech; Daniel B Mark
Journal:  J Med Syst       Date:  2009-08       Impact factor: 4.460

9.  Factors Associated With High Resource Use in Elective Adult Cardiac Surgery From 2005 to 2016.

Authors:  Young-Ji Seo; Sohail Sareh; Joseph Hadaya; Yas Sanaiha; Boback Ziaeian; Richard J Shemin; Peyman Benharash
Journal:  Ann Thorac Surg       Date:  2021-03-06       Impact factor: 4.330

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.